Who owns BHC
224 institutions reported holding BHC for 2026Q1, together 62% of the company, fewer than the 232 a quarter earlier.
224
Institutions reporting a position · as of 2026Q1 · down from 232 the quarter before
- Shares held by institutions
- 232.6M
Shares held by institutions · 62% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $1.26B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 37%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 32
- New positions
- 24
- Positions exited
- 35
- Added to
- 80
- Reduced
- 55
- Top 10 holdersof the company
- 45%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 224 | 232.6M | $1.26B |
| 2025Q4 | 232 | 235.8M | $1.64B |
| 2025Q3 | 217 | 240.5M | $1.55B |
| 2025Q2 | 210 | 246.2M | $1.64B |
| 2025Q1 | 227 | 243.7M | $1.58B |
| 2024Q4 | 223 | 253.2M | $1.99B |
| 2024Q3 | 208 | 255.0M | $2.09B |
| 2024Q2 | 233 | 280.6M | $1.96B |
| 2024Q1 | 234 | 283.4M | $2.95B |
| 2023Q4 | 233 | 286.0M | $2.29B |
| 2023Q3 | 221 | 281.7M | $2.32B |
| 2023Q2 | 230 | 265.2M | $2.12B |
| 2023Q1 | 233 | 277.7M | $2.25B |
| 2022Q4 | 260 | 286.4M | $1.81B |
| 2022Q3 | 281 | 244.9M | $1.70B |
| 2022Q2 | 322 | 241.1M | $2.02B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| PAULSON & CO INC | 73.3M | 20% | $396M |
| GOLDENTREE ASSET MANAGEMENT LP | 34.7M | 9.3% | $187M |
| ROYAL BANK OF CANADA | 11.4M | 3.0% | $61M |
| VANGUARD GROUP INC | 10.7M | 2.9% | $58M |
| NOMURA HOLDINGS INC | 9.0M | 2.4% | $49M |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 8.0M | 2.1% | $43M |
| MFN Partners Management, LP | 6.0M | 1.6% | $32M |
| Kohlberg Kravis Roberts & Co. L.P. | 5.2M | 1.4% | $28M |
| GOLDMAN SACHS GROUP INC | 5.2M | 1.4% | $28M |
| Hudson Bay Capital Management LP | 5.0M | 1.3% | $27M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - Specialty & Generic
Ranks #20 of 28 by Smart Score